PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 1604094

[Hepatitis A to E: current diagnosis].

H E Blum·E Walter
View original source ↗Export metadata ↓

Abstract

Diagnosis of viral hepatitis is based on epidemiologic data (information about travels, blood transfusions, contacts with persons suffering from hepatitis, etc.) and on results of physical examination and laboratory investigations. Usually, serologic and genomic analysis lead to the specific proof of the viral etiology: HAV, HBV/HDV, HCV and HEV. If these infections are not detected, nonviral causes of hepatopathy should be investigated (i.e. toxic, pharmaco-toxic, metabolic, immunologic, etc.).

Explore related subjects

Hepatitis AntibodiesHepatitis, Viral, HumanHumansImmunologic TechniquesPolymerase Chain ReactionEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H E Blum, E Walter. 1992-06-09. [Hepatitis A to E: current diagnosis].. https://pubmed.ncbi.nlm.nih.gov/1604094/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Comparison of real-time reverse transcriptase-polymerase chain reaction and nested or commercial reverse transcriptase-polymerase chain reaction for the detection of hepatitis E virus particle in human serum.

Hepatitis E virus (HEV) was originally identified as the causative agent of enterically transmitted non-A, non-B hepatitis. The virus is the 7.5-kb single-stranded positive RNA virus and has been classified in the genus Herpevirus [corrected] of the [corrected] Herpeviridae [corrected] Recently, HEVs were identified from several countries worldwide from human and animals including swine. Studies on the genomic analysis of HEV isolates and seroprevalence of anti-HEV antibodies suggested that HEV has been considered as a potent zoonotic agent. The HEV infection has been diagnosed by detection of anti-HEV antibodies or virus by using reverse transcriptase-polymerase chain reaction (RT-PCR) methods in the blood or feces. However, these diagnostic methods were not quantitative and not enough to diagnose small amounts of target molecules. Moreover, these methods were not adequate during the incubation period or early acute phase. To overcome these problems, real-time RT-PCR method was developed with a cloned viral DNA and in vitro transcribed cRNA in this study. The sensitivity of the reaction was 1.68 x 10(1) copies per reaction. Correlation coefficient values of the reactions in the repeated experiments were over 0.99. Ranges of slopes and coefficient variation values were from 3.341 to 3.435 and from 1.20 to 5.98, respectively. In comparison of the real-time PCR with nested or commercial RT-PCR, HEV particles could be detected in the negative samples, which were determined by conventional nested RT-PCR.

Hepatitis Antibodies↗
PubMed2005

Hepatitis E infections, Victoria, Australia.

In the first half of 2004, acute hepatitis E virus infections diagnosed in Victoria, Australia, increased 7-fold. Of the interviewed patients with highly reactive serologic results, 90% reported recent clinically compatible illness and overseas travel. The increase is compared with a background of exposure in countries in which hepatitis E is endemic.

Hepatitis Antibodies↗